Pointless CBD Bans Are Spreading Like, Well, CBD
Blame the FDA's trickle-down cautiousness
Clearing the way for additional research into those drugs will help craft public policy regarding their use, and could open the door to additional medical uses.
The DEA is resisting a recommendation that the cannabis-derived compound be moved to the least restrictive category of controlled substances.
Will the Medical Cannabis Research Act make it to the House floor?